Sponsors

Human papillomavirus vaccination

Analysis indicates that rates of high-grade cervical lesions decreased in young US women after vaccines were made available to protect against human papillomavirus (HPV), but the trend may be due in part to changes in cervical cancer screening recommendations.

CDC/Judy Schmidt; James Gathany

Published in the journal Cancer, the study illustrates some of the challenges in monitoring a vaccine’s impact during a time of concurrent changes in screening. More than half of high-grade cervical lesions that can lead to cancer are caused by persistent HPV infection that can be prevented if a person receives an HPV vaccine. Monitoring trends in the incidence of these lesions is helpful for evaluating the impact of HPV vaccination.

Latest Issues

BSMT 41st Annual Microbiology Conference

Royal Air Force Museum, Hendon, London
21 May, 2026

Clinical and Laboratory Haemostasis 2026

Sheffield Hallam University Atrium Conference Centre, Sheffield S1 1WB
3-4 June, 2026

LabMedUK26

The Eastside Rooms conference centre, Birmingham
8-10 June, 2026

London Biotechnology Show

Excel, London
9-10 June, 2026

Weqas Annual Laboratory Conference 2026

St Andrew’s Stadium, Birmingham
11th June 2026